• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts
    • MPR: Breakthrough Products Series
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Job Board
    • Leadership in Medtech
    • Manufacturer Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
    • DeviceTalks
  • Coronavirus: Live updates

Eyenovia Inc.

Eyenovia kicks off second Ph3 trial for pupil dilation tech

December 4, 2018 By Sarah Faulkner

Eyenovia (NSDQ:EYEN) said this week that it finished patient enrollment in its Phase III Mist-1 trial and enrolled the first patient in its second Phase III trial for the company’s combination eye solution delivered as a micro-dose using its Optejet device. The company is studying the therapy for pharmacologic mydriasis – pupil dilation for eye exams. […]

Filed Under: Clinical Trials, Drug-Device Combinations, Optical/Ophthalmic, Pharmaceutical, Wall Street Beat Tagged With: Eyenovia Inc.

Eyenovia touts publication of intraocular pressure data for micro-dose tech

November 29, 2018 By Sarah Faulkner

Eyenovia (NSDQ:EYEN) said this week that the results of its Phase II PG21 study were published in the Nov. issue of the journal Clinical Ophthalmology. The New York-based company’s Phase II study evaluated the effect of self-administered micro-dose latanoprost on intraocular pressure. Get the full story at our sister site, Drug Delivery Business News.

Filed Under: Clinical Trials, Drug-Device Combinations, Optical/Ophthalmic, Pharmaceutical, Wall Street Beat Tagged With: Eyenovia Inc.

Eyenovia launches Ph3 trial for pupil dilation tech

November 26, 2018 By Sarah Faulkner

Eyenovia (NSDQ:EYEN) said today that it enrolled the first patient in the first of two Phase III trials of the company’s MicroStat program. The Mist-1 and Mist-2 trials are slated to study the safety and efficacy of the company’s 2.5% phenylephrine, 1% tropicamide eye solution, delivered as a micro-dose using the Optejet device. Get the full […]

Filed Under: Clinical Trials, Drug-Device Combinations, Optical/Ophthalmic, Pharmaceutical, Wall Street Beat Tagged With: Eyenovia Inc.

20 medical device startups you need to know

April 13, 2018 By Chris Newmarker

There’s a lot of excitement these days around digital health. But there are actually many medical device startups out there in other spaces that continue to push the overall boundaries of medtech. From neuromodulation to drug delivery, surgical robotics and more, here’s a roundup of 20 medical device startups catching the eye of Medical Design […]

Filed Under: Business/Financial News, Cardiovascular, Drug-Device Combinations, Neuromodulation/Neurostimulation, News Well, Surgical Tagged With: 4cmedical, aspectbiosystems, Axonics Modulation Technologies, brainspec, cammed, clinicalsensors, cognitotherapeutics, dayzerodiagnostics, Eyenovia Inc., gel-e, Livongo, Medineering, metavention, patientory, portal instruments, prellisbiologics, reactiverobotics, rxfunction, sonexhealth, spryhealth, startups

SureFire Medical names pharma vet Szela as president, CEO | Personnel Moves – Jan. 26, 2018

January 26, 2018 By Sarah Faulkner

SureFire Medical has named pharma veteran Mary Szela as its president, CEO and board member, succeeding founder James Chomas, who has served as the company’s chief executive and president since 2009. Chomas will assume the role of chief technology officer and oncology strategy officer, focusing his efforts on the the company’s oncology drug-delivery tech. Get the […]

Filed Under: Drug-Device Combinations, Pharmaceutical, Wall Street Beat Tagged With: Aerie Pharmaceuticals, Eyenovia Inc., milestonescientific, oculartherapeutix, PolyPid, Surefire Medical

Eyenovia sets range for IPO

January 10, 2018 By Sarah Faulkner

N.Y.-based startup Eyenovia updated its regulatory filings to reveal that it plans to offer 2.73 million shares priced between $10 – $12 apiece in its initial public offering. The 7-person company, which is developing a device to deliver small doses of drugs to the eye, is applying to list on the Nasdaq exchange under the symbol, “EYEN”. Get the […]

Filed Under: Clinical Trials, Drug-Device Combinations, Funding Roundup, Optical/Ophthalmic, Pharmaceutical Tagged With: Eyenovia Inc.

Eyenovia looks to $35m IPO for ocular drug-delivery tech

December 20, 2017 By Sarah Faulkner

Eyenovia is looking to raise up to $35 million in an initial public offering, according to recent filings. The company plans to use the funds to support trials of its device, which is designed to deliver small doses of drugs to the eye. The New York-based company uses a piezo-electric dispensation technology to deliver microdoses of […]

Filed Under: Drug-Device Combinations, Food & Drug Administration (FDA), Funding Roundup, Initial Public Offering (IPO), Optical/Ophthalmic, Pharmaceutical Tagged With: Eyenovia Inc.

Eyenovia touts phase II study data

December 20, 2016 By Sarah Faulkner

Eyenovia Inc. touted data from its phase II study evaluating the safety and efficacy of its high-precision ophthalmic microtherapeutics compared to conventional eyedropper treatment. The trial comes on the heels of a previous phase II study published in Therapeutic Delivery in October. New York-based Eyenovia’s trial demonstrated that its microdosing achieved superior pharmacologic effects and […]

Filed Under: Clinical Trials, Drug-Device Combinations, Optical/Ophthalmic, Pharmaceutical Tagged With: Eyenovia Inc.

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by @MassDevice
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion

MASSDEVICE

Subscribe to MassDevice
Advertise with us
About
Contact us

Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS